| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $262K | — |
| Cost of Revenue | $187K | — |
| R&D Expense | $9.5M | +90.0% |
| SG&A Expense | $10.0M | +126.7% |
| Operating Income | -$19.4M | -106.4% |
| Income Tax | $850 | +6.3% |
| Net Income | -$19.2M | -146.6% |
| EPS (Basic) | -$0.62 | +53.4% |
| EPS (Diluted) | -$0.62 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -52.0% |
| Short-term Investments | $12.1M | — |
| Current Assets | $23.8M | +5.6% |
| Total Assets | $25.5M | +12.6% |
| Current Liabilities | $1.4M | +240.5% |
| Total Liabilities | $1.4M | +240.5% |
| Stockholders' Equity | $24.1M | +8.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.3M | -88.6% |
| Investing Cash Flow | -$13.3M | — |
| Financing Cash Flow | $18.2M | -24.6% |
| +53.4% |